Navigation Links
Queen Latifah Brings in the New Year with a Healthy Resolution
Date:1/10/2008

ead a very different campaign for the weight loss category - concentrating on a healthy lifestyle rather than getting into a specific dress size.

The on-demand version for the Jenny Craig Press Conference Webcast will be available for the next 30 days at http://72.32.208.177/webcast/jc/jenny_craig.htm.

About Jenny Craig

With its tailored YourStyle(R) program, Jenny Craig is committed to a personalized approach to weight loss by offering each client a one-on-one weekly consultation and a customized weight management plan designed to optimize individual success. The Jenny Craig YourStyle(R) program focuses on a comprehensive Food-Body-Mind curriculum designed to help clients manage their weight by creating a healthy relationship with food, building an active lifestyle and developing a balanced approach to living.

Jenny Craig, Inc., based in Carlsbad, CA, and owned by Nestle, is one of the world's largest weight management companies, with approximately 650 company-owned and franchised Centres in the United States, Canada, Australia, New Zealand and Puerto Rico.


'/>"/>
SOURCE Jenny Craig Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Sudden Cardiac Arrest Association Launches Long Island and Queens Chapters
2. Fluoridated water for Queensland ... at last
3. New York Hospital Queens Cardiac Rehabilitation Team Presents Study at Worlds Leading Heart Disease Conference
4. Queen Latifahs Travlin Light Tour to Be Sponsored by Jenny Craig
5. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Local Elementary and Middle Schools
6. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Pittsburgh-Area Elementary and Middle Schools
7. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Northern New Jersey Elementary and Middle Schools
8. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Kansas City Area Elementary and Middle Schools
9. Winter Brings Pet Hazards
10. PET/CT brings new hope to patients with deadly form of breast cancer
11. PET/CT Brings New Hope to Patients With Deadly Form of Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...ey Spears has been warned to stop drinking. Accord...d that she might have done irreparable damage to ...lor John Sundahl had told her: "If you fall off th...you will live. If you don't want to get sober for ...
...hat humans distant ancestors won the battle agains... left the human species vulnerable to HIV today. ...esent century and one of the most researched one s...d about its origin. Many researchers believe that ...
...shop owner was sentenced to two years probation fo...rced the evacuation of a rooming house beside his ...nts of sexual assault and one count of sexual expl...victims testified that Claro caressed and groped t...
...ermany have died of the feared H5N1 strain of bird...of a total of 14 birds tested positive for the H5N...itute institute said. A health official, Katja Gue...t tests carried out by the same institute confirme...
Other Medicine News:Health News:Ancient Ancestors Might Have Had a Clue to HIV 2Health News:Two Year Probation for Cobra Owner Helder Claro 2Health News:Six Cases of H5N1 Bird Flu Confirmed in Germany 2
(Date:10/13/2008)...ene(R)-F Surface Treatment Maximizes,Endothelializ...or Long-Term,Dual Antiplatelet Therapy, WASHINGTO...at today,s,"Innovative Devices and Futuristic Ther...r Cardiovascular Therapeutics (TCT) scientific,sym...oundation, presented,12-month follow-up data from ...
(Date:10/13/2008)...wswire/ -- Facet Solutions, Inc. today,announced t...from its US,IDE Pilot Study. The results show a 78...res, and an 80% reduction in Visual Analog Scores ...dent & CEO for Facet Solutions,added, "We are ver... not,only demonstrate significant pain relief but ...
(Date:10/10/2008)...f., Oct. 10 /-,XTENT, Inc. ...present,long-term follow-up data from the CUSTOM I...iovascular Research Foundation,s (CRF) twentieth a...CT) meeting in Washington, DC.,The CUSTOM clinical...igate,the safety and efficacy of the Custom NX(R) ...
(Date:10/10/2008)...ire-FirstCall/ -- Boston Scientific,Corporation (N...mpany,s major,events and press announcements at th...ieth annual Transcatheter Cardiovascular Therapeut...tober 12 to 17 in Washington, D.C., Boston Scient...,efficacy data on its TAXUS(R) Express2(TM) and se...
Breaking Medicine Technology:12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 212-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 312-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 4XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Stabilizing cancer fighting p53 can also shield a metastasis promoter 20062 1Stabilizing cancer fighting p53 can also shield a metastasis promoter 20062 2GlaxoSmithKline Announces 24500 000 in Fellowships at Stanford Graduate School of Business 20058 1GlaxoSmithKline Announces 24500 000 in Fellowships at Stanford Graduate School of Business 20058 2GlaxoSmithKline Announces 24500 000 in Fellowships at Stanford Graduate School of Business 20058 3Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market 20054 1Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market 20054 2ATHENA Clinical Results with Dronedarone 28Multaq 28R 29 29 Highlighted at the World Cardiology Congress 2174 1ATHENA Clinical Results with Dronedarone 28Multaq 28R 29 29 Highlighted at the World Cardiology Congress 2174 2ATHENA Clinical Results with Dronedarone 28Multaq 28R 29 29 Highlighted at the World Cardiology Congress 2174 3ATHENA Clinical Results with Dronedarone 28Multaq 28R 29 29 Highlighted at the World Cardiology Congress 2174 4ATHENA Clinical Results with Dronedarone 28Multaq 28R 29 29 Highlighted at the World Cardiology Congress 2174 5ATHENA Clinical Results with Dronedarone 28Multaq 28R 29 29 Highlighted at the World Cardiology Congress 2174 6
...007 /PRNewswire-FirstCall/ -- ZymoGenetics,Inc. t...d from a,Phase 1b clinical trial with atacicept in...e American Society of Clinical,Oncology (ASCO) 200...dministration of higher doses than had been tested...as well-tolerated and biologically,active at all d...
...SINESS WIRE)--Jun 4, 2007 - Acorda,Therapeutics, I...pany presented a "meta-analysis" or combined analy...tiple sclerosis during a,poster session at the Ame...ACTRIMS) Meeting in Washington, D.C. on Saturday, ...t Improvement in Walking,Speed on the Timed 25 Foo...
Other Medicine Technology:ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 2Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 4
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
Sugar-Chex Linearity is a whole blood formulation designed to cover the linear reportable range of the most popular glucose meters. The product meets CAP recommendations of using a control matrix tha
Medicine Products: